Monophasic demyelinating disease of the central nervous system associated with Hepatitis A infection.
Quaranta
L
L
Batocchi
A P
AP
Sabatelli
M
M
Nociti
V
V
Tartaglione
T
T
Cuonzo
F
F
Tonali
P A
PA
D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000956:Antigens, Viral / Q000276:immunology; D001323:Autoantibodies / Q000097:blood / Q000134:cerebrospinal fluid; D001921:Brain / Q000473:pathology / Q000503:physiopathology; D002490:Central Nervous System / Q000473:pathology* / Q000503:physiopathology*; D004673:Encephalomyelitis, Acute Disseminated / Q000175:diagnosis / Q000276:immunology* / Q000503:physiopathology*; D006506:Hepatitis A / Q000150:complications* / Q000276:immunology / Q000503:physiopathology; D030041:Hepatitis A virus / Q000276:immunology; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D018716:Molecular Mimicry / Q000276:immunology; D013116:Spinal Cord / Q000473:pathology / Q000503:physiopathology; D016896:Treatment Outcome
D000890:Anti-Infective Agents; D000956:Antigens, Viral; D001323:Autoantibodies; D008775:Methylprednisolone